REP. DINGELL PUTTING INDIRECT PRESSURE ON BOLAR TO COME CLEAN

REP. DINGELL PUTTING INDIRECT PRESSURE ON BOLAR TO COME CLEAN "concerning false documents" submitted to the House Energy & Commerce/Oversight Subcommittee in its investigation of FDA's generic approval process. In a March 19 letter to Lt. General Charles McCausland, USAF, who is considering debarring Bolar from Defense Department contracts, Rep. John Dingell (D-Mich.) expressed the subcommittee's "continuing concern about the lack of full cooperation...by Bolar's new management, as well as about Bolar's now legendary misdeeds." Dingell noted that the subcommittee had asked Bolar, in a Jan. 23 letter to the company's legal counsel, to make "a full and public accounting concerning the false documents submitted to the subcommittee." At that time, the subcommittee also asked the company to release the results of its own internal investigations. "None of this information has been provided," Dingell pointed out. "Even had there been belated cooperation, Bolar's misbehavior has been so extensive that it would support significant enforcement action." In addition, the Michigan congressman characterized Bolar's "unwillingness to cooperate with federal authorities...and to disclose the full nature and extent of its efforts to subvert" the investigation as "particularly grave matters." Bolar said that although it has not yet responded to Dingell's request for information, the company is cooperating with the Justice Department's investigation of the the firm.